Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome
George Z Rassidakis, L Jeffrey Medeiros, Simonetta Viviani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial
Yasuhiro Oki, Michael S Ewer, Daniel J Lenihan, et al.
Plos One
|
March 15, 2018
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
British Journal of Haematology
|
June 26, 2013
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Philippe Armand, Yasuhiro Oki, Donna S Neuberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
Alison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma
Chelsea C Pinnix, Grace L Smith, Sarah Milgrom, et al.
Cancer
|
May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma
Jorge E Romaguera, Michael Wang, Lei Feng, et al.
British Journal of Haematology
|
December 17, 2016
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography
Chelsea C Pinnix, Bouthaina Dabaja, Mohamed Amin Ahmed, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 19, 2019
NCCN Guidelines Insights: Survivorship, Version 2.2019
Tara Sanft, Crystal S Denlinger, Saro Armenian, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome
George Z Rassidakis, L Jeffrey Medeiros, Simonetta Viviani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial
Yasuhiro Oki, Michael S Ewer, Daniel J Lenihan, et al.
Plos One
|
March 15, 2018
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
British Journal of Haematology
|
June 26, 2013
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Philippe Armand, Yasuhiro Oki, Donna S Neuberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
Alison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma
Chelsea C Pinnix, Grace L Smith, Sarah Milgrom, et al.
Cancer
|
May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma
Jorge E Romaguera, Michael Wang, Lei Feng, et al.
British Journal of Haematology
|
December 17, 2016
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography
Chelsea C Pinnix, Bouthaina Dabaja, Mohamed Amin Ahmed, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 19, 2019
NCCN Guidelines Insights: Survivorship, Version 2.2019
Tara Sanft, Crystal S Denlinger, Saro Armenian, et al.
Page
of 5